Michael D. is an experienced Pharma/Biotech drug discovery executive with a robust background in oncology and medicinal chemistry. They served as the Chief Scientific Officer and Head of Drug Discovery at IDEAYA Biosciences, playing a pivotal role in the company's growth and IPO. Previously, as Global Head Oncology Chemistry at Novartis, Michael led significant advancements in clinical oncology compounds. Currently, they are a co-founder at Delphia Therapeutics, where they are pioneering new cancer treatment paradigms, and serve as a scientific advisor for intoDNA, driving innovation in DNA damage detection. Michael holds a Ph.D. in Total Synthesis of Natural Products from the University of Bristol.
This person is not in the org chart
This person is not in any teams
This person is not in any offices